iBio IBIO
NASDAQ IBIO
$1.12 +0.01 (+0.90%)
At close: Oct 2, 2026 · 4:00 PM EDT

iBio (IBIO) Price to FCF (2012)

Updated

iBio's (IBIO) Price to FCF was 342.82 for fiscal Q3 2012 (quarter ended Mar 31, 2012).

Analysis

iBio (IBIO) Price to FCF (2012) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 iBio 116.55 Mn 116.55 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2012 342.82
API Access

iBio Price to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-fcf&ticker=IBIO&period=max&api_key=YOUR_API_KEY